Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Lipitor

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Lipitor was produced by Pfizer and Astellas.

Pfizer set to unveil Mylan merger and spin-off

Pfizer set to unveil Mylan merger and spin-off

Its biggest off-patent brands would include drugs such as Pfizer’s Lipitor, Viagra and Mylan’s Epipen.

The handover: Pfizer reshapes itself for a new era

The handover: Pfizer reshapes itself for a new era autonomous. Created in the summer reshuffle, the Established Medicines division includes the majority of Pfizer’s off-patent blockbuster pills, including Lyrica, Lipitor, Norvasc and Viagra, and a number of other

Pfizer names next CEO as Read retires

Pfizer names next CEO as Read retires Ian Read’s tenure has had plenty of ups and downs, and undoubtedly one of his biggest challenges was overcoming the patent expiry of its mega-blockbuster Lipitor in November 2011. ... Pfizer slipped down the rankings in the years following the loss of

Using social data to see patients more clearly

Using social data to see patients more clearly Drugs and databases analysed. The study focused on two drugs, aspirin and Lipitor, that had a relatively high prevalence among the ADR reports in both the clinical and the social media ... In both data sets, musculoskeletal pain and cramps were among the

Pharma set for a strong 2015 as drug sales jump

Pharma set for a strong 2015 as drug sales jump Pfizer was in fact the hardest hit, with its once $13bn a year statin Lipitor (atorvastatin) losing its patents in 2011/12, with sales falling by $10bn in just two years.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
certain health

Transforming the way health brands and companies communicate, we deliver creative science led, insight-driven solutions that give award winning results...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...